Crowdonomics
All companies
Neopenda logo

Neopenda

Operating

Neopenda, PBC

Healthcare · Chicago, IL · Founded 2018

Woman-founded
Valuation cap
$6.0M
As of Dec 2018 · from Reg CF Offering (2018) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$298,924
Across 2 rounds since 2018

Financials

FY2016–FY2024 (no data for FY2021, FY2022) · from SEC filings · hover any figure for its source
$193K
−$16K
2016
2017
$159K
$3K
2018
$108K
−$185K
2019
$103K
−$715K
2020
2021no data
2022no data
$24K
−$570K
2023
$66K
−$587K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2016
FY2017
FY2018
FY2019
FY2020
FY2023
FY2024
Income statement
Revenue
$193,148
$158,745
$107,592
$102,625
$24,242
$66,381
Cost of goods sold
$0
$0
$0
$0
$11,728
$61,493
Gross margin
100%
100%
100%
100%
52%
7%
Net income
-$15,769
$2,730
-$185,203
-$715,019
-$569,637
-$586,867
Taxes paid
$0
$0
$0
$0
$41,396
$27,203
Balance sheet
Cash
$37,040
$37,354
$72,756
$101,040
$123,199
$31,896
Accounts receivable
$0
$0
$0
$0
$14,683
$34,756
Total assets
$37,040
$37,367
$72,756
$123,095
$182,821
$106,401
Short-term debt
$0
$530
$1,122
$0
$12,235
$56,683
Long-term debt
$0
$0
$200,000
$966,481
$3,008,481
$3,438,481
Total liabilities
$0
$530
$201,122
$966,481
$3,020,716
$3,495,164
Other
Headcount
2
2
4
10

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Post-money = pre-money + amount raised · caps marked
$6.0M
Valuation cap
Reg CF Offering (2018)

A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.

Fundraising history

Reg CF Offering (2025)ClosedReg CF · Convertible Note · via WeFunder
Raised $0 / $618K
Reg CF Offering (2018)ClosedReg CF · SAFE · via Republic
Raised $298.9K / $1.1MInvestors 694Valuation cap $6M

Team

2 people
Sona ShahFounder
CEO & Co-founder
Teresa CauvelFounder
CTO & Co-founder

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFiled Form C-TR (terminated reporting)

Filed 2 of 8 annual reports (FY2018–FY2025)

694 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form C/AApr 28, 20260001751635-26-000002
    EDGAR
  • Form CApr 18, 20250001670254-25-000379
    EDGAR
  • Form C-TRApr 21, 20200001751635-20-000004
    EDGAR
  • Form C-ARApr 21, 20200001751635-20-000002
    EDGAR
  • Form C-ARApr 30, 20190001751635-19-000003
    EDGAR
  • Form C-UJan 22, 20190001751635-19-000001
    EDGAR
  • Form C/ASep 24, 20180001751635-18-000005
    EDGAR
  • Form C/ASep 21, 20180001751635-18-000004
    EDGAR
Source: SEC EDGARCIK 0001751635DELast synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.